Bio Green Med Solution, Inc. — Director's Dealing 2020

Nov 12, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2020-11-09

Reporting Person: Walker Karin L (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-09	Stock Option (right to buy)	$3.33	A	5200	Acquired	2030-11-09	Common Stock (5200)	Direct

Footnotes

F1: These options were granted to Ms. Walker for her services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.